embecta to Participate in Investor Events
PARSIPPANY, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:
Wells Fargo 2026 Healthcare Conference
Management will host one-on-one investor meetings on Wednesday, September 9, 2026, at the Encore Boston Harbor Hotel in Everett, Boston, MA.
J.P. Morgan 4th Annual Nashville Healthcare Conference 2026
Management will host a fireside chat on Thursday, September 10, 2026, at 8:00 a.m. CT, as well as one-on-one investor meetings, at the Joseph Hotel, Nashville.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,500 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
| Contacts: | |
| Media | Investors |
| Christian Glazar | Patricia Gonzalez |
| Sr. Director, Corporate Communications | VP, Corporate FP&A and Investor Relations |
| 908-821-6922 | 862-341-2809 |
| Contact Media Relations | Contact IR |
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
This Once-Hot AI Stock Now Looks Deeply Undervalued
5 Stocks to Buy Trading at Big Discounts
Tech Stocks Sell Off as Intel, Amazon Earnings Spook Investors
2 Undervalued AI Stocks With Room to Run
United States